• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Chiara Bergonzi, A. Giani, Mirella Blini, Sylvia Marchi, Saverio Luccarelli, Giovanni Staurenghi
  • Medicine
  • Journal of glaucoma
  • 2010 (First Publication: 1 December 2010)
  • PURPOSE To determine if treatment with prostaglandin (PG) analogues affects keratocyte density as an indirect measure of extracellular matrix in the corneal stroma. PATIENTS AND METHODS In thisContinue Reading
  • Gemma Caterina Maria Rossi, Mirella Blini, +6 authors Paolo Emilio Bianchi
  • Medicine
  • Journal of ocular pharmacology and therapeutics…
  • 2013 (First Publication: 1 November 2013)
  • PURPOSE To record the impact of preservative-free Tafluprost on corneal status examined by in vivo confocal microscopy. METHODS A prospective cohort study on consecutive naïve or previously treatedContinue Reading
  • Gemma Caterina Maria Rossi, Gian Maria Pasinetti, +5 authors Paolo Emilio Bianchi
  • Medicine
  • Expert opinion on drug safety
  • 2012 (First Publication: 1 July 2012)
  • Objectives: The aim of this study was to evaluate the safety of preservative-free tafluprost in newly diagnosed patients and to confirm its efficacy in lowering intraocular pressure (IOP). Methods:Continue Reading
  • Mirella Blini, Gemma Caterina Maria Rossi, +5 authors Roberto Ratiglia
  • Medicine
  • 2009 (First Publication: 1 January 2009)
  • ABSTRACT Objective: To evaluate the intraocular pressure (IOP) lowering efficacy and safety of travoprost 0.004% in patients with open-angle glaucoma or ocular hypertension, poorly controlled with orContinue Reading
  • Mirella Blini, Gemma Caterina Maria Rossi, +5 authors Roberto Ratiglia
  • Medicine
  • Current medical research and opinion
  • 2009
  • OBJECTIVE To evaluate the intraocular pressure (IOP) lowering efficacy and safety of travoprost 0.004% in patients with open-angle glaucoma or ocular hypertension, poorly controlled with orContinue Reading